{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:27Z","timestamp":1787003667139,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Michael J. Fox Foundation for Parkinson\u2019s Research","award":["MJFF-021151"],"award-info":[{"award-number":["MJFF-021151"]}]},{"name":"Michael J. Fox Foundation for Parkinson\u2019s Research","award":["MJFF-021151"],"award-info":[{"award-number":["MJFF-021151"]}]},{"name":"Michael J. Fox Foundation for Parkinson\u2019s Research","award":["MJFF-021151"],"award-info":[{"award-number":["MJFF-021151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11979-8","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T06:56:02Z","timestamp":1756450562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alpha-synuclein is increased in erythrocytes in parkinson\u2019s disease cases"],"prefix":"10.1038","volume":"15","author":[{"given":"Ryan N.","family":"Coyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"Issue 9996","key":"11979_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LVM Kalia","year":"2015","unstructured":"Kalia, L. V. M., Dr Anthony, E. & Lang, M. D. Parkinson\u2019s disease. Lancet. 386 (Issue 9996), 896\u2013912 (2015).","journal-title":"Lancet Volume"},{"issue":"6645","key":"11979_CR2","first-page":"839","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein Lewy bodies. Nature 388 (6645), 839\u2013840 (1997).","journal-title":"\u03b1-Synuclein Lewy Bodies Nat."},{"issue":"5321","key":"11979_CR3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-Synuclein gene identified in families with parkinson\u2019s disease. Science 276 (5321), 2045\u20132047 (1997).","journal-title":"Science"},{"key":"11979_CR4","doi-asserted-by":"crossref","unstructured":"Iwanaga, K. et al. Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases. Neurology (1999).","DOI":"10.1212\/WNL.52.6.1269"},{"key":"11979_CR5","doi-asserted-by":"crossref","unstructured":"Fumimura, Y. et al. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease. J. Neuropathol. Exp. Neurol. (2007).","DOI":"10.1097\/nen.0b013e3180517454"},{"issue":"6","key":"11979_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach, T. G. et al. Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with lewy body disorders. Acta Neuropathol. 119 (6), 689\u2013702 (2010).","journal-title":"Acta Neuropathol."},{"key":"11979_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.imbio.2015.10.002","volume":"221","author":"A Shameli","year":"2016","unstructured":"Shameli, A. et al. A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology 221, 333\u2013340 (2016).","journal-title":"Immunobiology"},{"issue":"12","key":"11979_CR8","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/acn3.50944","volume":"6","author":"AS Elhadi","year":"2019","unstructured":"Elhadi, A. S. et al. \u03b1-Synuclein in blood cells differentiates parkinson\u2019s disease from healthy controls. Ann. Clin. Transl. Neurol. 6 (12), 2426\u20132436 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"40","key":"11979_CR9","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-Synuclein in Familial and sporadic lewy body disease. J. Biol. Chem. 281 (40), 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"11979_CR10","doi-asserted-by":"publisher","first-page":"13713","DOI":"10.1038\/s41598-017-14175-5","volume":"7","author":"VH Miranda","year":"2017","unstructured":"Miranda, V. H. et al. Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for parkinson\u2019s disease. Sci. Rep. 7 (1), 13713 (2017).","journal-title":"Sci. Rep."},{"key":"11979_CR11","doi-asserted-by":"crossref","unstructured":"Li, X. Y. et al. Alterations of erythrocytic phosphorylated alpha-synuclein in different subtypes and stages of parkinson\u2019s disease. Front. Aging Neurosci. (2021).","DOI":"10.3389\/fnagi.2021.623977"},{"issue":"5","key":"11979_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22 (5), 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"11979_CR13","doi-asserted-by":"crossref","unstructured":"Kuzkina, A. et al. Diagnostic value of skin RT-QuIC in parkinson\u2019s disease: a two-laboratory study. Npj. Parkinson\u2019s Dis. 7 (1) (2021).","DOI":"10.1038\/s41531-021-00242-2"},{"key":"11979_CR14","doi-asserted-by":"crossref","unstructured":"Liguori, R. et al. A comparative blind study between skin biopsy and seed amplification assay to disclose pathological \u03b1-synuclein in RBD. NPJ Parkinson\u2019s Dis. 9 (1) (2023).","DOI":"10.1038\/s41531-023-00473-5"},{"key":"11979_CR15","doi-asserted-by":"publisher","unstructured":"Okuzumi, A. et al. Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat. Med. 29 (6), 1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9 (2023). Erratum in: Nat. Med. 31 (2), 698 (2025).","DOI":"10.1038\/s41591-023-02358-9"},{"key":"11979_CR16","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. A minimally invasive biomarker for sensitive and accurate diagnosis of parkinson\u2019s disease. MedRxiv. https:\/\/doi.org\/10.1101\/2024.06.29.24309703 (2024). Update in: Acta Neuropathol. Commun. 12 (1), 167 (2024).","DOI":"10.1101\/2024.06.29.24309703"},{"key":"11979_CR17","unstructured":"Chen, C. H. & Lin, L. B. Integrated plasma and neuroimaging biomarkers associated with motor and cognition severity in parkinson\u2019s disease.  J. Parkinsons Dis. (2020)."},{"issue":"1","key":"11979_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi, M. et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in parkinson\u2019s disease. Neurosci. Lett. 480 (1), 78\u201382 (2010).","journal-title":"Neurosci. Lett."},{"key":"11979_CR19","doi-asserted-by":"crossref","unstructured":"Mata, I. F. et al. SNCA variant associated with Parkinson disease and plasma \u03b1-synuclein level. Arch. Neurol. 67 (11) (2010).","DOI":"10.1001\/archneurol.2010.279"},{"key":"11979_CR20","doi-asserted-by":"publisher","unstructured":"Foulds, P. G. et al. A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci. Rep. 3, 2540. https:\/\/doi.org\/10.1038\/srep02540 (2013).","DOI":"10.1038\/srep02540"},{"issue":"2","key":"11979_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"RKK Barbour","year":"2008","unstructured":"Barbour, R. K. K. et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 5 (2), 55\u201359 (2008).","journal-title":"Neurodegener Dis."},{"key":"11979_CR22","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","volume":"20","author":"LM Chahine","year":"2014","unstructured":"Chahine, L. M. et al. Blood-based biomarkers for parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, S99\u2013S103 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"11979_CR23","doi-asserted-by":"crossref","unstructured":"Thiagarajan, P. et al. How do red blood cells die? Front. Physiol. (2021).","DOI":"10.3389\/fphys.2021.655393"},{"issue":"8","key":"11979_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00216-020-02439-5","volume":"412","author":"S Klatt","year":"2020","unstructured":"Klatt, S. et al. Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Anal. Bioanal. Chem. 412 (8), 1879\u20131892 (2020).","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"11979_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"KA Ellis","year":"2009","unstructured":"Ellis, K. A. et al. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of alzheimer\u2019s disease. Int. Psychogeriatr. 21 (4), 672\u2013687 (2009).","journal-title":"Int. Psychogeriatr."},{"key":"11979_CR26","doi-asserted-by":"publisher","unstructured":"Tian, C. et al. Erythrocytic \u03b1-synuclein as a potential biomarker for parkinson\u2019s disease. Transl. Neurodegener. 8. https:\/\/doi.org\/10.1186\/s40035-019-0155-y (2019).","DOI":"10.1186\/s40035-019-0155-y"},{"key":"11979_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00210-005-0009-2","volume":"372","author":"PA Lang","year":"2005","unstructured":"Lang, P. A. et al. Inhibition of erythrocyte apoptosis by catecholamines. Naunyn Schmied Arch. Pharmacol. 372, 228\u2013235. https:\/\/doi.org\/10.1007\/s00210-005-0009-2 (2005).","journal-title":"Naunyn Schmied Arch. Pharmacol."},{"issue":"2","key":"11979_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12185-018-2457-8","volume":"108","author":"K Araki","year":"2018","unstructured":"Araki, K. et al. The localization of \u03b1-synuclein in the process of differentiation of human erythroid cells. Int. J. Hematol. 108 (2), 130\u2013138 (2018).","journal-title":"Int. J. Hematol."},{"key":"11979_CR29","doi-asserted-by":"crossref","unstructured":"Li, W. et al. Receptor-dependent endocytosis mediates \u03b1-synuclein oligomer transport into red blood cells. Front. Aging Neurosci. 14 (2022).","DOI":"10.3389\/fnagi.2022.899892"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11979-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11979-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11979-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:32:47Z","timestamp":1757449967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11979-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11979"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11979-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Blaine Roberts receives research support from ThermoFisher, Agilent technologies, and Bruker.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31837"}}